Modulating the detrimental effects of DKK1 has emerged as an effective approach for preventing bone loss associated with estrogen deficiency, excessive glucocorticoid exposure, and osteoarthritis-related joint damage (Wang et al. 2007, 2008; Weng et al. 2012). Here, DKK1 is linked to osteoarthritis.